Where is Nuvation Bio Inc. (NUVB) Headed According to Wall Street Analysts?

Nuvation Bio Inc. (NYSE:NUVB) is one of the best small-cap stocks with huge growth potential. Nuvation Bio Inc. (NYSE:NUVB) announced on February 9 the finalization of a protocol amendment to the ongoing global SIGMA study of safusidenib that expands it to a Phase 3 trial. Safusidenib is a novel, oral, potent, brain-penetrant targeted inhibitor of mutant IDH1, and SIGMA is involved in the evaluation of the efficacy and safety of safusidenib versus placebo for the maintenance treatment of patients with high ...